{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T15:23:08Z","timestamp":1779290588841,"version":"3.51.4"},"reference-count":94,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"unspecified","delay-in-days":49,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014653","name":"NIHR Manchester Biomedical Research Centre","doi-asserted-by":"crossref","award":["NIHR203308"],"award-info":[{"award-number":["NIHR203308"]}],"id":[{"id":"10.13039\/100014653","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012041","name":"Arthritis UK","doi-asserted-by":"crossref","award":["21754"],"award-info":[{"award-number":["21754"]}],"id":[{"id":"10.13039\/501100012041","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012041","name":"Arthritis UK","doi-asserted-by":"crossref","award":["21818"],"award-info":[{"award-number":["21818"]}],"id":[{"id":"10.13039\/501100012041","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["RMD Open"],"accepted":{"date-parts":[[2026,3,28]]},"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:p>Rheumatoid arthritis (RA) susceptibility is strongly influenced by genetic variations within the major histocompatibility complex, with HLA-DRB1 risk alleles representing the largest contributors to heritability, particularly in seropositive (anti-citrullinated protein antibody positive) disease. The shared epitope (SE) hypothesis, first proposed more than three decades ago, explained the clustering of susceptibility within HLA-DRB1*04 subtypes. Subsequent fine-mapping expanded HLA-DRB1 disease associations beyond the SE motif, identifying key amino acid residues at positions 11\/13, in addition to 71 and 74, that account for much of the genetic contribution to susceptibility in seropositive RA. Recent studies demonstrate that these residues not only determine risk of developing seropositive RA but also stratify disease outcome (ie, radiographic progression or mortality), with valine at position 11 or histidine at position 13 as central determinants. However, their role in response to treatment remains unclear. Structural work has partially elucidated the molecular basis of these associations, showing that SE-bearing HLA-DR molecules preferentially bind nonpolar or negatively charged amino acids and directly engage T cell receptors, while genetic data support a role in shaping thymic repertoire selection. However, only a few RA autoantigens have been identified so far. Beyond professional antigen-presenting cells, HLA-DR expression is found on fibroblasts in the inflamed synovium and activated lymphocytes, where its function remains unknown. Importantly, HLA-DRB1 association to RA is not unique; HLA-DRB1 alleles contribute pleiotropically to the susceptibility of a wide range of autoimmune diseases, reflecting fundamental roles in immune regulation. This review synthesises established findings and current uncertainties in HLA-DRB1 research, identifying outstanding challenges and opportunities for translation into precision medicine.<\/jats:p>","DOI":"10.1136\/rmdopen-2025-006045","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T14:30:22Z","timestamp":1779287422000},"page":"e006045","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["HLA-DR risk variants in rheumatoid arthritis: what we know and still do not know"],"prefix":"10.1136","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5256-5642","authenticated-orcid":false,"given":"Chuan Fu","family":"Yap","sequence":"first","affiliation":[{"name":"Arthritis UK Centre for Genetics and Genomics, Centre for Musculoskeletal Research, Division of Musculoskeletal and Dermatological Sciences, The University of Manchester, Manchester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6471-3358","authenticated-orcid":false,"given":"Sebastien","family":"Viatte","sequence":"additional","affiliation":[{"name":"Arthritis UK Centre for Genetics and Genomics, Centre for Musculoskeletal Research, Division of Musculoskeletal and Dermatological Sciences, The University of Manchester, Manchester, UK"},{"name":"Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK"},{"name":"NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"key":"2026052007301641000_12.2.e006045.1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B"},{"key":"2026052007301641000_12.2.e006045.2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780120602"},{"key":"2026052007301641000_12.2.e006045.3","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/tan.14642","article-title":"Nomenclature for factors of the HLA system, update January, February, and March 2022","volume":"99","author":"Marsh","year":"2022","journal-title":"HLA"},{"key":"2026052007301641000_12.2.e006045.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197804202981602"},{"key":"2026052007301641000_12.2.e006045.5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0004.1989.tb03185.x"},{"key":"2026052007301641000_12.2.e006045.6","first-page":"738","article-title":"HLA-linked rheumatoid arthritis","volume":"55","author":"Hasstedt","year":"1994","journal-title":"Am J Hum Genet"},{"key":"2026052007301641000_12.2.e006045.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2836(03)00750-2"},{"key":"2026052007301641000_12.2.e006045.8","doi-asserted-by":"crossref","unstructured":"Silver J , Goyert SM . Epitopes are the functional units of hla class ii molecules and form the molecular basis for disease susceptibility. In: HLA class II antigens: a comprehensive review of structure and function. 1986: 32\u201348.","DOI":"10.1007\/978-3-642-70367-6_3"},{"key":"2026052007301641000_12.2.e006045.9","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780301102"},{"key":"2026052007301641000_12.2.e006045.10","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0b013e328336ba63"},{"key":"2026052007301641000_12.2.e006045.11","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.86.24.10049"},{"key":"2026052007301641000_12.2.e006045.12","doi-asserted-by":"publisher","DOI":"10.1186\/ar1767"},{"key":"2026052007301641000_12.2.e006045.13","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1399-0039.1991.tb01853.x","article-title":"Nomenclature for factors of the HLA system, 1990","volume":"37","author":"Bodmer","year":"1991","journal-title":"Tissue Antigens"},{"key":"2026052007301641000_12.2.e006045.14","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-201225"},{"key":"2026052007301641000_12.2.e006045.15","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/art.43298","article-title":"Comparative effectiveness of abatacept versus adalimumab in shared epitope positive and negative patients with rheumatoid arthritis","volume":"78","author":"Yap","year":"2026","journal-title":"Arthritis Rheumatol"},{"key":"2026052007301641000_12.2.e006045.16","doi-asserted-by":"crossref","DOI":"10.1186\/ar2975","article-title":"Influence of HLA DRB1 alleles in the susceptibility of rheumatoid arthritis and the regulation of antibodies against citrullinated proteins and rheumatoid factor","volume":"12","author":"Balsa","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"2026052007301641000_12.2.e006045.17","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddu387"},{"key":"2026052007301641000_12.2.e006045.18","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2013-204749","article-title":"High-density genotyping of immune loci in Koreans and Europeans identifies eight new rheumatoid arthritis risk loci","volume":"74","author":"Kim","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2026052007301641000_12.2.e006045.19","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1399-0039.1993.tb01973.x","article-title":"HLA-DR1 and rheumatoid arthritis in Israeli Jews: sequencing reveals that DRB1*0102 is the predominant HLA-DR1 subtype","volume":"41","author":"de Vries","year":"1993","journal-title":"Tissue Antigens"},{"key":"2026052007301641000_12.2.e006045.20","article-title":"Shared HLA class II in six autoimmune diseases in Latin America: a meta-analysis","volume":"2012","author":"Cruz-Tapias","year":"2012","journal-title":"Autoimmune Dis"},{"key":"2026052007301641000_12.2.e006045.21","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2119\/molmed.2014.00097","article-title":"Immunochip identifies novel, and replicates known, genetic risk loci for rheumatoid arthritis in black South Africans","volume":"20","author":"Govind","year":"2014","journal-title":"Mol Med"},{"key":"2026052007301641000_12.2.e006045.22","doi-asserted-by":"crossref","DOI":"10.1186\/ar2945","article-title":"Diagnostic value of anti-cyclic citrullinated peptides and association with HLA-DRB1 shared epitope alleles in African rheumatoid arthritis patients","volume":"12","author":"Singwe-Ngandeu","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"2026052007301641000_12.2.e006045.23","doi-asserted-by":"publisher","DOI":"10.1002\/art.23166"},{"key":"2026052007301641000_12.2.e006045.24","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nature22329","article-title":"Dominant protection from HLA-linked autoimmunity by antigen-specific regulatory T cells","volume":"545","author":"Ooi","year":"2017","journal-title":"Nature New Biol"},{"key":"2026052007301641000_12.2.e006045.25","doi-asserted-by":"publisher","DOI":"10.1038\/ng.1076"},{"key":"2026052007301641000_12.2.e006045.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2014.02.013"},{"key":"2026052007301641000_12.2.e006045.27","doi-asserted-by":"publisher","DOI":"10.1038\/gene.2011.79"},{"key":"2026052007301641000_12.2.e006045.28","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215114"},{"key":"2026052007301641000_12.2.e006045.29","doi-asserted-by":"publisher","DOI":"10.1002\/art.11251"},{"key":"2026052007301641000_12.2.e006045.30","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211300"},{"key":"2026052007301641000_12.2.e006045.31","doi-asserted-by":"publisher","DOI":"10.1002\/art.10210"},{"key":"2026052007301641000_12.2.e006045.32","doi-asserted-by":"publisher","DOI":"10.1038\/gene.2011.60"},{"key":"2026052007301641000_12.2.e006045.33","doi-asserted-by":"publisher","DOI":"10.1002\/art.30636"},{"key":"2026052007301641000_12.2.e006045.34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150283","article-title":"Imputing variants in HLA-DR beta genes reveals that HLA-DRB1 is solely associated with rheumatoid arthritis and systemic lupus erythematosus","volume":"11","author":"Kim","year":"2016","journal-title":"PLoS ONE"},{"key":"2026052007301641000_12.2.e006045.35","doi-asserted-by":"publisher","DOI":"10.1086\/516736"},{"key":"2026052007301641000_12.2.e006045.36","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3379"},{"key":"2026052007301641000_12.2.e006045.37","doi-asserted-by":"crossref","DOI":"10.1038\/srep25014","article-title":"Major histocompatibility complex harbors widespread genotypic variability of non-additive risk of rheumatoid arthritis including epistasis","volume":"6","author":"Wei","year":"2016","journal-title":"Sci Rep"},{"key":"2026052007301641000_12.2.e006045.38","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-221754"},{"key":"2026052007301641000_12.2.e006045.39","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nature12873","article-title":"Genetics of rheumatoid arthritis contributes to biology and drug discovery","volume":"506","author":"Okada","year":"2014","journal-title":"Nature New Biol"},{"key":"2026052007301641000_12.2.e006045.40","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-022-01213-w"},{"key":"2026052007301641000_12.2.e006045.41","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.3435"},{"key":"2026052007301641000_12.2.e006045.42","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/art.39018","article-title":"Association of valine and leucine at HLA-DRB1 position 11 with radiographic progression in rheumatoid arthritis, independent of the shared epitope alleles but not independent of anti-citrullinated protein antibodies","volume":"67","author":"van Steenbergen","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2026052007301641000_12.2.e006045.43","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1002\/art.39780","article-title":"HLA-DRB1 amino acid positions 11\/13, 71, and 74 are associated with inflammation level, disease activity, and the health assessment questionnaire score in patients with inflammatory polyarthritis","volume":"68","author":"Ling","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2026052007301641000_12.2.e006045.44","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-022-02775-0","article-title":"HLA-DRB1 haplotypes predict cardiovascular mortality in inflammatory polyarthritis independent of CRP and anti-CCP status","volume":"24","author":"Sharma","year":"2022","journal-title":"Arthritis Res Ther"},{"key":"2026052007301641000_12.2.e006045.45","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-016-1174-z","article-title":"A genetic risk score composed of rheumatoid arthritis risk alleles, HLA-DRB1 haplotypes, and response to TNFi therapy - results from a Swedish cohort study","volume":"18","author":"Jiang","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"2026052007301641000_12.2.e006045.46","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-56987-2","article-title":"Association of HLA-DRB1 locus with treatment response to abatacept or TNF inhibitors in patients with seropositive rheumatoid arthritis","volume":"14","author":"Cha","year":"2024","journal-title":"Sci Rep"},{"key":"2026052007301641000_12.2.e006045.47","doi-asserted-by":"crossref","first-page":"15250","DOI":"10.1038\/s41598-023-42324-6","article-title":"Carriers of HLA-DRB1*04:05 have a better clinical response to abatacept in rheumatoid arthritis","volume":"13","author":"Inoue","year":"2023","journal-title":"Sci Rep"},{"key":"2026052007301641000_12.2.e006045.48","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s42358-024-00352-4","article-title":"Comparative effectiveness of abatacept versus TNF inhibitors in rheumatoid arthritis patients who are ACPA and shared epitope positive","volume":"64","author":"Harrold","year":"2024","journal-title":"Adv Rheumatol"},{"key":"2026052007301641000_12.2.e006045.49","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2024-226024"},{"key":"2026052007301641000_12.2.e006045.50","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-223955"},{"key":"2026052007301641000_12.2.e006045.51","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2012.237"},{"key":"2026052007301641000_12.2.e006045.52","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature01661","article-title":"Evolving concepts of rheumatoid arthritis","volume":"423","author":"Firestein","year":"2003","journal-title":"Nature New Biol"},{"key":"2026052007301641000_12.2.e006045.53","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/rheumatology\/keab624","article-title":"The Cusp theory: is there more to HLA-disease association?","volume":"61","author":"van Drongelen","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"2026052007301641000_12.2.e006045.54","doi-asserted-by":"publisher","DOI":"10.1097\/00000441-200404000-00006"},{"key":"2026052007301641000_12.2.e006045.55","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.86.2.636"},{"key":"2026052007301641000_12.2.e006045.56","doi-asserted-by":"crossref","first-page":"e712","DOI":"10.1016\/S2665-9913(20)30344-1","article-title":"Autoantigens in rheumatoid arthritis and the potential for antigen-specific tolerising immunotherapy","volume":"2","author":"Nel","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"2026052007301641000_12.2.e006045.57","doi-asserted-by":"publisher","DOI":"10.1084\/jem.181.5.1847"},{"key":"2026052007301641000_12.2.e006045.58","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80369-6"},{"key":"2026052007301641000_12.2.e006045.59","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.171.2.538"},{"key":"2026052007301641000_12.2.e006045.60","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1002\/art.38637","article-title":"Citrulline-specific Th1 cells are increased in rheumatoid arthritis and their frequency is influenced by disease duration and therapy","volume":"66","author":"James","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2026052007301641000_12.2.e006045.61","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00494"},{"key":"2026052007301641000_12.2.e006045.62","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/art.40768","article-title":"Citrullinated Aggrecan Epitopes as Targets of Autoreactive CD 4+ T Cells in Patients With Rheumatoid Arthritis","volume":"71","author":"Rims","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"2026052007301641000_12.2.e006045.63","doi-asserted-by":"crossref","unstructured":"Song J , Schwenzer A , Wong A , et al . Shared recognition of citrullinated tenascin-C peptides by T and B cells in rheumatoid arthritis. JCI Insight 2021;6. doi:10.1172\/jci.insight.145217","DOI":"10.1172\/jci.insight.145217"},{"key":"2026052007301641000_12.2.e006045.64","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-04291-8"},{"key":"2026052007301641000_12.2.e006045.65","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20131241"},{"key":"2026052007301641000_12.2.e006045.66","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA117.001013"},{"key":"2026052007301641000_12.2.e006045.67","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1002\/art.39553","article-title":"A novel HLA-DRB1*10:01-restricted T-cell epitope from citrullinated type II collagen relevant to rheumatoid arthritis","volume":"68","author":"Chemin","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2026052007301641000_12.2.e006045.68","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1186\/s13075-016-1153-4","article-title":"The increased ability to present citrullinated peptides is not unique to HLA-SE molecules: arginine-to-citrulline conversion also enhances peptide affinity for HLA-DQ molecules","volume":"18","author":"Kampstra","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"2026052007301641000_12.2.e006045.69","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177140","article-title":"Citrullination only infrequently impacts peptide binding to HLA class II MHC","volume":"12","author":"Sidney","year":"2017","journal-title":"PLoS ONE"},{"key":"2026052007301641000_12.2.e006045.70","doi-asserted-by":"crossref","unstructured":"Lim JJ , Jones CM , Loh TJ , et al . The shared susceptibility epitope of HLA-DR4 binds citrullinated self-antigens and the TCR. Sci Immunol 2021;6. doi:10.1126\/sciimmunol.abe0896","DOI":"10.1126\/sciimmunol.abe0896"},{"key":"2026052007301641000_12.2.e006045.71","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-022-01032-z"},{"key":"2026052007301641000_12.2.e006045.72","doi-asserted-by":"crossref","first-page":"930112","DOI":"10.3389\/fimmu.2022.930112","article-title":"How RA-associated HLA-DR molecules contribute to the development of antibodies to citrullinated proteins: the hapten\u2013carrier model","volume":"13","author":"Roudier","year":"2022","journal-title":"Front Immunol"},{"key":"2026052007301641000_12.2.e006045.73","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1713112114"},{"key":"2026052007301641000_12.2.e006045.74","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/art.41189","article-title":"Peptidylarginine deiminase autoimmunity and the development of anti-citrullinated protein antibody in rheumatoid arthritis: the hapten\u2013carrier model","volume":"72","author":"Auger","year":"2020","journal-title":"Arthritis & Rheumatology"},{"key":"2026052007301641000_12.2.e006045.75","doi-asserted-by":"crossref","first-page":"102542","DOI":"10.1016\/j.jaut.2020.102542","article-title":"Do RA associated HLA-DR molecules bind citrullinated peptides or peptides from PAD4 to help the development of RA specific antibodies to citrullinated proteins?","volume":"116","author":"Balandraud","year":"2021","journal-title":"J Autoimmun"},{"key":"2026052007301641000_12.2.e006045.76","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/art.43295","article-title":"A tolerogenic plasmid inhibits autoantibody production triggered by immunisation with human peptidyl arginine deiminase 4","volume":"78","author":"Pagni","year":"2026","journal-title":"Arthritis Rheumatol"},{"key":"2026052007301641000_12.2.e006045.77","doi-asserted-by":"publisher","DOI":"10.1111\/cei.13256"},{"key":"2026052007301641000_12.2.e006045.78","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2024.11.004"},{"key":"2026052007301641000_12.2.e006045.79","doi-asserted-by":"crossref","DOI":"10.1186\/ar3848","article-title":"T-cell autoreactivity to citrullinated autoantigenic peptides in rheumatoid arthritis patients carrying HLA-DRB1 shared epitope alleles","volume":"14","author":"Law","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"2026052007301641000_12.2.e006045.80","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2018.04.004"},{"key":"2026052007301641000_12.2.e006045.81","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa9301","article-title":"Citrullinated peptide dendritic cell immunotherapy in HLA risk genotype-positive rheumatoid arthritis patients","volume":"7","author":"Benham","year":"2015","journal-title":"Sci Transl Med"},{"key":"2026052007301641000_12.2.e006045.82","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208456"},{"key":"2026052007301641000_12.2.e006045.83","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/1583647","article-title":"Synovial macrophages in rheumatoid arthritis: the past, present, and future","volume":"2020","author":"Tu","year":"2020","journal-title":"Mediators Inflamm"},{"key":"2026052007301641000_12.2.e006045.84","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/art.41958","article-title":"Effect of JAK inhibition on the induction of proinflammatory HLA-DR+CD90+ rheumatoid arthritis synovial fibroblasts by interferon-\u03b3","volume":"74","author":"Zhao","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"2026052007301641000_12.2.e006045.85","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1002\/art.42839","article-title":"Expansion of HLA-DR-positive peripheral helper T and naive B cells in anticitrullinated protein antibody-positive individuals at risk for rheumatoid arthritis","volume":"76","author":"Takada","year":"2024","journal-title":"Arthritis Rheumatol"},{"key":"2026052007301641000_12.2.e006045.86","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1094872","article-title":"Automated clustering reveals CD4+ T cell subset imbalances in rheumatoid arthritis","volume":"14","author":"Mulhearn","year":"2023","journal-title":"Front Immunol"},{"key":"2026052007301641000_12.2.e006045.87","doi-asserted-by":"crossref","unstructured":"Inamo J , Keegan J , Griffith A , et al . Deep immunophenotyping reveals circulating activated lymphocytes in individuals at risk for rheumatoid arthritis. J Clin Invest 2025;135. doi:10.1172\/JCI185217","DOI":"10.1172\/JCI185217"},{"key":"2026052007301641000_12.2.e006045.88","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-016-8817-7"},{"key":"2026052007301641000_12.2.e006045.89","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/art.42760","article-title":"Using polygenic risk scores to aid diagnosis of patients with early inflammatory arthritis: results from the Norfolk Arthritis Register","volume":"76","author":"Hum","year":"2024","journal-title":"Arthritis Rheumatol"},{"key":"2026052007301641000_12.2.e006045.90","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s13075-021-02612-w","article-title":"Impact of the HLA-DRB1 shared epitope on responses to treatment with tofacitinib or abatacept in patients with rheumatoid arthritis","volume":"23","author":"Hirose","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"2026052007301641000_12.2.e006045.91","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1457213","article-title":"Fifty years of HLA-associated type 1 diabetes risk: history, current knowledge, and future directions","volume":"15","author":"Noble","year":"2024","journal-title":"Front Immunol"},{"key":"2026052007301641000_12.2.e006045.92","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3395"},{"key":"2026052007301641000_12.2.e006045.93","doi-asserted-by":"crossref","DOI":"10.3390\/cells8101180","article-title":"Update on the genetics of systemic lupus erythematosus: genome-wide association studies and beyond","volume":"8","author":"Kwon","year":"2019","journal-title":"Cells"},{"key":"2026052007301641000_12.2.e006045.94","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0140-6736(15)00465-1","article-title":"Inherited determinants of Crohn\u2019s disease and ulcerative colitis phenotypes: a genetic association study","volume":"387","author":"Cleynen","year":"2016","journal-title":"The Lancet"}],"container-title":["RMD Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/rmdopen-2025-006045","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T14:30:31Z","timestamp":1779287431000},"score":1,"resource":{"primary":{"URL":"https:\/\/rmdopen.bmj.com\/lookup\/doi\/10.1136\/rmdopen-2025-006045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":94,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,5,20]]},"published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10.1136\/rmdopen-2025-006045"],"URL":"https:\/\/doi.org\/10.1136\/rmdopen-2025-006045","relation":{},"ISSN":["2056-5933"],"issn-type":[{"value":"2056-5933","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]}}}